Skip to Main Content

Paper Details

Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials.
BMJ
17
2023
CRD42019128391, bisphosphonates, denosumab, oestrogen, oestrogen receptor, osteoporosis, osteoporotic fractures, parathyroid hormone receptor, patients, postmenopausal, vertebral fractures, women
Author NameAffiliation
Daniel Prieto-AlhambraUniversity of Oxford
Daniel Prieto-AlhambraErasmus University Medical Center
Daniel Prieto-AlhambraUniversity of Oxford
Daniel Prieto-AlhambraErasmus University Medical Center
  • 1 - 4

Datasets

Release 1.2